Cardonilmab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cardonilmab, covering 2024-11-01 to 2024-11-01. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer [Phase 2]